Leonteq Securities AG Boosts Stock Position in Humana Inc. $HUM

Leonteq Securities AG grew its position in Humana Inc. (NYSE:HUM) by 185.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,196 shares of the insurance provider’s stock after purchasing an additional 5,328 shares during the period. Leonteq Securities AG’s holdings in Humana were worth $1,421,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Montag A & Associates Inc. increased its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC raised its position in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in Humana during the 4th quarter valued at approximately $27,000. Reflection Asset Management acquired a new stake in Humana during the 4th quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton boosted its holdings in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research reports. Leerink Partners increased their price objective on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research note on Thursday, April 30th. Zacks Research raised shares of Humana from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 13th. Truist Financial increased their price target on Humana from $270.00 to $320.00 and gave the stock a “hold” rating in a research report on Monday, June 1st. UBS Group reiterated a “neutral” rating on shares of Humana in a research note on Monday, June 15th. Finally, Morgan Stanley boosted their price objective on Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, Humana has an average rating of “Hold” and an average target price of $293.09.

Humana Stock Performance

Shares of NYSE HUM opened at $396.38 on Friday. The company has a market capitalization of $47.59 billion, a PE ratio of 42.39, a price-to-earnings-growth ratio of 2.26 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company’s fifty day moving average price is $321.87 and its 200 day moving average price is $250.56. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $415.00.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, research analysts predict that Humana Inc. will post 9.03 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is currently 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.